As of January 24, 2025, RxSight (RXST) has a market cap of $1.29 billion USD. According to our data, RxSight is ranked No.4826 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 24, 2025 | $1.29 B |
-7.18%
|
Dec 31, 2024 | $1.39 B |
-14.73%
|
Dec 29, 2023 | $1.63 B |
218.23%
|
Dec 30, 2022 | $0.51 B |
12.62%
|
Dec 31, 2021 | $0.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alcon
ALC
|
$44.29 B |
0.214 B
|
Switzerland
|
Bausch + Lomb
BLCO
|
$6.01 B |
0.000 M
|
Canada
|
STAAR Surgical
STAA
|
$1.14 B |
0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$353.05 B |
-0.000 M
|
USA
|
Hoya
7741.T
|
$47.36 B |
-0.222 B
|
Japan
|
EssilorLuxottica
EL.PA
|
$120.60 B |
0.000 M
|
France
|
Cooper Companies
COO
|
$19.10 B |
0.001 M
|
USA
|
Novartis
NVS
|
$201.57 B |
1.587 B
|
Switzerland
|
Santen Pharmaceutical
4536.T
|
$3.43 B |
13.120 M
|
Japan
|
Glaukos
GKOS
|
$8.83 B |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
LENSAR
LNSR
|
$96.75 M |
-0.000 M
|
USA
|
Market Cap | = | RXST Stock Price | * | RXST Shares Outstanding |
= | $31.91 | * | 40.30 M | |
= | $1.29 B |